US, B., P, K., NM, P., M, K., K, S., M, M., . . . D, C. (2025). Flavopiridol: A promising cyclin-dependent kinase inhibitor in cancer treatment. Naunyn-Schmiedeberg's archives of pharmacology, 398(4), 3489. https://doi.org/10.1007/s00210-024-03599-2
Chicago Style (17th ed.) CitationUS, Baghel, et al. "Flavopiridol: A Promising Cyclin-dependent Kinase Inhibitor in Cancer Treatment." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 4 (2025): 3489. https://doi.org/10.1007/s00210-024-03599-2.
MLA (9th ed.) CitationUS, Baghel, et al. "Flavopiridol: A Promising Cyclin-dependent Kinase Inhibitor in Cancer Treatment." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 4, 2025, p. 3489, https://doi.org/10.1007/s00210-024-03599-2.
Warning: These citations may not always be 100% accurate.
